Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 3/20 | 0.47 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.47 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 7/20 | 0.40 |
| ▸ | NPC1 | O15118 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19848322 | 1.00 | KEAP1 (0.47) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL31473739 | 0.88 | KEAP1 (0.44) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL20512796 | 0.84 | KEAP1 (0.41) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL33527170 | 0.80 | SLC9A1 (0.38) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL33526133 | 0.80 | SLC9A1 (0.38) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL12100525 | 0.75 | HCAR3 (0.54) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL1161406 | 0.75 | SLC9A1 (0.53) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL19911635 | 0.74 | KEAP1 (0.47) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL22732809 | 0.74 | KEAP1 (0.47) | KEAP1SLC9A1HCAR3RAB9ANPC1 | |
| SCHEMBL19848287 | 0.74 | KEAP1 (0.47) | KEAP1SLC9A1HCAR3RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | KEAP1 3874/4885SLC9A1 515/4885HCAR3 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.